CIK 0001822462 · Non-accelerated filer<br>Smaller reporting company
Foghorn Therapeutics Inc.
Sign in to watch- Ticker
- FHTX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- 617-586-3100
- Business address
- 500 TECHNOLOGY SQUARE, SUITE 700, CAMBRIDGE, MA, 02139
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-01-22 | GOTTSCHALK ADRIAN Chief Executive Officer | Grant or award · Stock Option (right to buy) | +400,000 | $4.37 | $1.7M | 400,000 |
| 2025-01-22 | Bellon Steven F. Chief Scientific Officer | Grant or award · Stock Option (right to buy) | +140,000 | $4.37 | $612K | 140,000 |
| 2025-01-22 | LaCascia Michael Chief Legal Officer | Grant or award · Stock Option (right to buy) | +126,000 | $4.37 | $551K | 126,000 |
| 2024-09-23 | Costa Carlos Chief People Officer | Option exercise 10b5-1 | +857 | $3.72 | $3K | 857 |
| 2024-09-23 | Costa Carlos Chief People Officer | Sale 10b5-1 | −857 | $10.17 | $9K | 0 |
| 2024-09-23 | Costa Carlos Chief People Officer | Option exercise · Stock Option (right to buy) 10b5-1 | −857 | 39,789 | ||
| 2024-09-20 | Costa Carlos Chief People Officer | Option exercise 10b5-1 | +35,756 | $3.72 | $133K | 35,756 |
| 2024-09-20 | Costa Carlos Chief People Officer | Sale 10b5-1 | −35,756 | $10.04 | $359K | 0 |
| 2024-09-20 | Costa Carlos Chief People Officer | Option exercise · Stock Option (right to buy) 10b5-1 | −35,756 | 40,646 | ||
| 2024-09-18 | Costa Carlos Chief People Officer | Option exercise 10b5-1 | +11,574 | $3.72 | $43K | 11,574 |
| 2024-09-18 | Costa Carlos Chief People Officer | Sale 10b5-1 | −11,574 | $10.05 | $116K | 0 |
| 2024-09-18 | Costa Carlos Chief People Officer | Option exercise · Stock Option (right to buy) 10b5-1 | −11,574 | 76,402 | ||
| 2024-09-17 | Costa Carlos Chief People Officer | Option exercise 10b5-1 | +10,272 | $3.72 | $38K | 10,272 |
| 2024-09-17 | Costa Carlos Chief People Officer | Sale 10b5-1 | −10,272 | $10.04 | $103K | 0 |
| 2024-09-17 | Costa Carlos Chief People Officer | Option exercise · Stock Option (right to buy) 10b5-1 | −10,272 | 87,976 | ||
| 2024-09-16 | Costa Carlos Chief People Officer | Option exercise 10b5-1 | +400 | $3.72 | $1K | 400 |
| 2024-09-16 | Costa Carlos Chief People Officer | Sale 10b5-1 | −400 | $10.00 | $4K | 0 |
| 2024-09-16 | Costa Carlos Chief People Officer | Option exercise · Stock Option (right to buy) 10b5-1 | −400 | 98,248 | ||
| 2024-09-09 | Bellon Steven F. Chief Scientific Officer | Sale 10b5-1 | −20,000 | $9.50 | $190K | 101,957 |
| 2024-09-03 | Rivkin Anna Chief Business Officer | Grant or award · Stock Options (Right to buy) | +190,000 | $7.85 | $1.5M | 190,000 |
Page 3 of 9 · 177 trades